NAGE
Niagen Bioscience, Inc. Common Stock
NAGE
NAGE
61 hedge funds and large institutions have $32.7M invested in Niagen Bioscience, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
61
Holders Change
-3
Holders Change %
-4.69%
% of All Funds
1.36%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
7
Increased
16
Reduced
14
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Bank of New York Mellon
New York
|
+$83.8K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$77K |
| 3 |
BFM
Boothbay Fund Management
New York
|
+$60K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$59.5K |
| 5 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$57.7K |
Top Sellers
| 1 |
OC
Oppenheimer & Co
New York
|
-$146K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$126K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
-$93K |
| 4 |
Jane Street
New York
|
-$90K |
| 5 |
WSTAM
Wilbanks Smith & Thomas Asset Management
Norfolk,
Virginia
|
-$86K |
